Annual Accounts Payable
$1.28 M
-$403.00 K-23.90%
December 31, 2023
Summary
- As of February 6, 2025, LRMR annual accounts payable is $1.28 million, with the most recent change of -$403.00 thousand (-23.90%) on December 31, 2023.
- During the last 3 years, LRMR annual accounts payable has fallen by -$1.35 million (-51.29%).
- LRMR annual accounts payable is now -63.75% below its all-time high of $3.54 million, reached on December 31, 2019.
Performance
LRMR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.69 M
-$1.23 M-42.20%
September 30, 2024
Summary
- As of February 6, 2025, LRMR quarterly accounts payable is $1.69 million, with the most recent change of -$1.23 million (-42.20%) on September 30, 2024.
- Over the past year, LRMR quarterly accounts payable has dropped by -$1.23 million (-42.20%).
- LRMR quarterly accounts payable is now -52.36% below its all-time high of $3.54 million, reached on December 31, 2019.
Performance
LRMR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
LRMR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -23.9% | -42.2% |
| 3 y3 years | -51.3% | -42.2% |
| 5 y5 years | -63.8% | -42.2% |
LRMR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -23.9% | at low | -42.2% | +296.7% |
| 5 y | 5-year | -63.8% | at low | -52.4% | +296.7% |
| alltime | all time | -63.8% | at low | -52.4% | +296.7% |
Larimar Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.69 M(-42.2%) |
| Jun 2024 | - | $2.92 M(+52.1%) |
| Mar 2024 | - | $1.92 M(+49.5%) |
| Dec 2023 | $1.28 M(-23.9%) | $1.28 M(+69.7%) |
| Sep 2023 | - | $756.00 K(-67.7%) |
| Jun 2023 | - | $2.34 M(+237.3%) |
| Mar 2023 | - | $695.00 K(-58.8%) |
| Dec 2022 | $1.69 M | $1.69 M(+98.6%) |
| Sep 2022 | - | $849.00 K(+99.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $425.00 K(-82.4%) |
| Mar 2022 | - | $2.42 M(+45.6%) |
| Dec 2021 | $1.66 M(-37.0%) | $1.66 M(-6.0%) |
| Sep 2021 | - | $1.77 M(+20.7%) |
| Jun 2021 | - | $1.46 M(-54.7%) |
| Mar 2021 | - | $3.23 M(+22.6%) |
| Dec 2020 | $2.63 M(-25.6%) | $2.63 M(+107.6%) |
| Sep 2020 | - | $1.27 M(-43.8%) |
| Jun 2020 | - | $2.26 M(-36.2%) |
| Dec 2019 | $3.54 M | $3.54 M |
FAQ
- What is Larimar Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Larimar Therapeutics?
- What is Larimar Therapeutics annual accounts payable year-on-year change?
- What is Larimar Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Larimar Therapeutics?
- What is Larimar Therapeutics quarterly accounts payable year-on-year change?
What is Larimar Therapeutics annual accounts payable?
The current annual accounts payable of LRMR is $1.28 M
What is the all time high annual accounts payable for Larimar Therapeutics?
Larimar Therapeutics all-time high annual accounts payable is $3.54 M
What is Larimar Therapeutics annual accounts payable year-on-year change?
Over the past year, LRMR annual accounts payable has changed by -$403.00 K (-23.90%)
What is Larimar Therapeutics quarterly accounts payable?
The current quarterly accounts payable of LRMR is $1.69 M
What is the all time high quarterly accounts payable for Larimar Therapeutics?
Larimar Therapeutics all-time high quarterly accounts payable is $3.54 M
What is Larimar Therapeutics quarterly accounts payable year-on-year change?
Over the past year, LRMR quarterly accounts payable has changed by -$1.23 M (-42.20%)